Gastro-oesophageal Reflux Disease Trial, Recruiting (NCT07506356)

Gastro-oesophageal Reflux Disease Trial, Recruiting NCT07506356 Sponsor: University Hospital, Geneva Condition: Gastro-oesophageal Reflux Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07506356 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Gord

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with Type 2 Diabetes
People who have been taking a GLP-1 analog medication for more than 3 months
People who have signed a consent form agreeing to take part
People with an ASA physical status classification between I and IV (this is a health rating scale used by anaesthetists — confirm with trial site what this means for your situation)

Who may not be able to join:

People who are currently being treated with insulin
People who have a condition that affects how their digestive system moves food through the gut
People who have had stomach surgery in the past
People who have a hiatal hernia (where part of the stomach pushes up through the diaphragm)
People who have experienced a recent physical trauma or injury
People who are unable to lie down for the examination
People who are unable to follow instructions during the examination, for example due to a language barrier or dementia
People with a BMI over 40
People who are unable to stop smoking for 12 hours before the measurements are taken

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07506356

Sponsor: University Hospital, Geneva

Phase: Not Applicable

Status: Recruiting

Condition: Gastro-oesophageal Reflux Disease

More information: https://clinicaltrials.gov/study/NCT07506356

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older
People who have been diagnosed with Type 2 Diabetes
People who have been taking a GLP-1 analog medication for more than 3 months
People who have signed a consent form agreeing to take part
People with an ASA physical status classification between I and IV (this is a health rating scale used by anaesthetists — confirm with trial site what this means for your situation)

Who may not be able to join:

People who are currently being treated with insulin
People who have a condition that affects how their digestive system moves food through the gut
People who have had stomach surgery in the past
People who have a hiatal hernia (where part of the stomach pushes up through the diaphragm)
People who have experienced a recent physical trauma or injury
People who are unable to lie down for the examination
People who are unable to follow instructions during the examination, for example due to a language barrier or dementia
People with a BMI over 40
People who are unable to stop smoking for 12 hours before the measurements are taken

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University Hospital, Geneva

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

31 December 2026

Where this trial is recruiting

🇨🇭 Switzerland

Primary endpoints

A safe gastric volume for anesthesia in diabetic patients treated with GLP-1 analog after a 6 hours fasting period 7 day after the last injection.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov